Pharmacotherapy of pediatric and adolescent HIV infection | Zendy

Susan Schuval | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmacotherapy of pediatric and adolescent HIV infection

Author(s) -

Susan Schuval

Publication year - 2009

Publication title -

therapeutics and clinical risk management

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.719

H-Index - 55

eISSN - 1178-203X

pISSN - 1176-6336

DOI - 10.2147/tcrm.s4594

Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , pharmacotherapy , antiretroviral drug , intensive care medicine , antiretroviral agents , pediatrics , viral load , immunology

Significant advances have been made in the treatment of human immunodeficiency virus (HIV) infection over the past two decades. Improved therapy has prolonged survival and improved clinical outcome for HIV-infected children and adults. Sixteen antiretroviral (ART) medications have been approved for use in pediatric HIV infection. The Department of Health and Human Services (DHHS) has issued "Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection", which provide detailed information on currently recommended antiretroviral therapies (ART). However, consultation with an HIV specialist is recommended as the current therapy of pediatric HIV therapy is complex and rapidly evolving.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research